Validation study of mHealth technology in HIV to improve Empowerment and healthcare utilisation: Research and innovation to Generate Evidence for personalised care.
This study is designed to evaluate the introduction of the mHealth platform (app) into routine care for people living with stable HIV infection – looking at patient empowerment, quality of life, patient experience and usability, alongside clinical outcomes and adherence. We will also be looking at health economics outcomes.
People living with HIV are living longer, healthier lives and many people are seeking to reduce the impact of their infection on their day-to-day lives.
HIV services are looking for ways to minimise the impact of treatment for those living with stable infection whilst making sure that those with more complex medical needs can be given the time that they need to be seen by an appropriate clinician.
There is an increasing use of technology within health – particularly within the field of health-related apps, with apps available for many chronic conditions.
In Brighton an email service has been running since 2008 reducing the number of visits that those with stable HIV infection make to clinic – more than 500 individuals now see their clinician once a year with their interim results checked and emailed to them.
Within the EmERGE study we are building on the experience of our partners in Brighton and Barcelona by developing and evaluating a pathway of care for people living with stable HIV infection. The pathway is designed to reduce the number of visits that someone needs to make to the clinic and to enable individuals to see their results and other information on their mobile phones. This study aims to recruit 3,808 patients across five different clinical sites. The clinical sites taking part in this study are in Antwerp, Barcelona, Brighton, Lisbon and Zagreb.